Melasma is a form of hyperpigmentation characterized by symmetrical, diffuse patches of brownish or grey-brown discoloration typically appearing on the cheeks, upper lip, forehead, and nose bridge. It is far more common in women than men, particularly in those with medium-to-dark skin tones, and it is driven by a complex interplay of hormonal factors, UV exposure, and genetic predisposition that makes it one of the most frustrating pigmentation concerns to manage. Unlike post-inflammatory dark marks, which tend to have clear edges and a single cause, melasma is deeper, more diffuse, and more prone to recurrence.
The defining characteristic of melasma — and the reason it requires a different approach from other hyperpigmentation — is that its melanocytes remain chronically sensitized. Treatment can suppress their overactivity and produce significant visible lightening, but the underlying sensitivity remains. Sun exposure, heat, hormonal changes, or stopping treatment can re-trigger darkening weeks after impressive fading was achieved. This is not treatment failure: it is the nature of the condition, and understanding it is what shifts the approach from a 'course of treatment' mindset to a long-term maintenance strategy.
What causes melasma and why it's stubborn
Melasma is caused by the overstimulation of melanocytes in a pattern influenced by three converging factors. Hormonal triggers — elevated estrogen and progesterone from pregnancy (where it is called 'chloasma' or the 'mask of pregnancy'), hormonal contraception, or hormonal fluctuations — activate a UV-sensitization pathway in facial skin that makes melanocytes dramatically more responsive to light. This is why melasma that develops during pregnancy can reappear with any subsequent UV exposure even years later.
UV and visible light (including certain wavelengths from screens and indoor lighting) are the most important triggers for active melasma flares. The condition is particularly common in climates with high UV index year-round and in women with skin types III–V (Fitzpatrick scale), whose more reactive melanocytes amplify the hormonal signal. Genetics plays a strong role — family history is a significant predictor. Topical and systemic therapies can produce meaningful fading, but if UV triggers are not controlled, recurrence is essentially certain.
- Hormonal triggers: pregnancy, oral contraceptives, hormone therapy — activates a UV-sensitization pathway
- UV and visible light: the main flare trigger — even through windows, even on cloudy days
- Fitzpatrick types III–V: melanocytes are more reactive, melasma is more common and deeper
- Genetics: strong family history association
- Heat: a less-studied but clinically recognized melasma trigger independent of UV
What the evidence says about treatment
Dermatologist evaluation is the right starting point for melasma — a Wood's lamp examination or dermoscopy can determine whether the pigmentation is epidermal (more treatable) or dermal (deeper, more resistant), which significantly affects prognosis and treatment selection. Prescription triple combination cream (tretinoin + hydroquinone + a topical corticosteroid) remains the gold standard for epidermal melasma in clinical guidelines, producing significant lightening within eight to twelve weeks. This is not available over the counter and requires medical supervision.
At the topical OTC level, the strongest evidence supports: tranexamic acid (the most convincing newer ingredient for melasma specifically, with multiple clinical trials), azelaic acid (anti-inflammatory and melanin-inhibiting, with good tolerability in all skin tones), vitamin C in the morning, and niacinamide. These work best as a stack rather than individually. Consistent broad-spectrum SPF 50 with some UVA protection beyond the minimum (look for PA+++ or higher, or contain zinc oxide/titanium dioxide) is non-negotiable — it is both treatment and maintenance.
- Tranexamic acid — strongest OTC evidence for melasma; interferes with UV-triggered melanocyte activation
- Azelaic acid (10–20%) — melanin inhibitor + anti-inflammatory; well-tolerated across skin tones
- Vitamin C — antioxidant protection and tyrosinase inhibition; morning use under SPF
- Niacinamide (5%) — blocks melanin transfer, mild anti-inflammatory
- SPF 50+ broad-spectrum — essential; consider mineral (zinc oxide) for better UVA coverage and heat tolerance
- Prescription options (via dermatologist): tretinoin, hydroquinone combination, chemical peels, laser (carefully selected)
Managing melasma long-term
The most important mindset shift with melasma is from 'treatment' to 'management.' Significant improvement is achievable — many people achieve near-complete fading with consistent treatment and rigorous UV protection. But the melanocyte sensitization underlying melasma does not fully resolve, which means that ongoing SPF, heat avoidance, and maintenance use of brightening actives are the realistic long-term picture rather than a one-time cure.
Any plans to address melasma with professional interventions (chemical peels, laser) should be discussed with a board-certified dermatologist experienced in treating melasma in your skin tone. Some laser wavelengths and improper chemical peel selection can worsen melasma, particularly in deeper skin tones, by triggering post-inflammatory hyperpigmentation. This is a genuine concern, not a scare tactic — careful selection by a knowledgeable provider matters here more than in most other pigmentation treatments.
Rosee's on-device face scan reads tone evenness across the cheeks, forehead, and perioral area — the characteristic distribution pattern of melasma — without ever sending your photo off your iPhone. For melasma specifically, tracking is most useful for monitoring response to treatment over the weeks and months that meaningful fading requires, and for detecting early signs of recurrence so you can respond before a significant flare develops. Because melasma can be difficult to assess in variable lighting conditions (it often appears to lighten and darken with different lights), a consistent morning scan under similar conditions creates a more reliable record than daily mirror checks alone. Rosee provides honest scores — if lighting conditions are poor for an accurate read, it says so rather than returning a flattering number.